SB-505124 hydrochloride
CAS No. 356559-13-2
SB-505124 hydrochloride ( —— )
产品货号. M33750 CAS No. 356559-13-2
SB-505124 hydrochloride 是一种选择性的?TGF-β Receptor type I receptor (ALK4,ALK5,ALK7) 抑制剂,对 LK4,ALK5 的?IC50 值分别为 129 nM 和 47 nM,对 ALK1,2,3 或 6 无作用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥548 | 有现货 |
|
| 10MG | ¥872 | 有现货 |
|
| 25MG | ¥1423 | 有现货 |
|
| 50MG | ¥2120 | 有现货 |
|
| 100MG | ¥3051 | 有现货 |
|
| 500MG | ¥6957 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SB-505124 hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SB-505124 hydrochloride 是一种选择性的?TGF-β Receptor type I receptor (ALK4,ALK5,ALK7) 抑制剂,对 LK4,ALK5 的?IC50 值分别为 129 nM 和 47 nM,对 ALK1,2,3 或 6 无作用。
-
产品描述SB-505124 hydrochloride is a selective inhibitor of?TGF-β Receptor type I receptor (ALK4, ALK5, ALK7), with?IC50s?of 129 nM and 47 nM for?ALK4, ALK5, respectively, but it does not inhibit ALK1, 2, 3, or 6.
-
体外实验SB-505124 demonstrates no toxicity to renal epithelial A498 cells at concentrations up to 100 μM for 48 h. 505124 inhibits the closely related ALK4 with an IC50 value of 129±11 nM (about 2.5-fold less sensitive than ALK5) but does not inhibit ALK2 at concentrations up to 10 μM. SB-505124 (1 μM) inhibits the TGF-β-induced phosphorylation of Smad2 in all three of these cell lines in a concentration-dependent fashion. SB-505124 (1 or 5 μM) potently inhibits TGF-β-induced activation of JNK/SAP, extracellular signal-regulated kinase 1/2, and p38 despite the different patterns of activation in these cells. SB-505124 (10 μM) impairs Smad2 phosphorylation and CTGF and α-SMA expression in vitro. SB-505124 susspresses CTGF and α-SMA observed by immunofluorescence. Cell outgrowth from explants dissected from eyes to which SB-505124 is applied during GFS is robust while outgrowth is poor from those treated with MMC.
-
体内实验SB-505124 (5 mg/kg; i.p.) alone has no effect in C57Bl6 mice with A549 xenografts, but administration of SB-505124 with a single dose of Carboplatin (60 mg/kg) results in durable responses without the need for maintenance therapy in five animals.Animal Model:C57Bl6 mice with A549 xenografts Dosage:5 mg/kg Administration:I.p.; daily Result:Had no effect alone, but administration with a single dose of carboplatin (60 mg/kg) resulted in durable responses without the need for maintenance therapy in five animals.
-
同义词——
-
通路Angiogenesis
-
靶点ALK
-
受体ALK
-
研究领域——
-
适应症——
化学信息
-
CAS Number356559-13-2
-
分子量371.86
-
分子式C20H22ClN3O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?Methanol 中的溶解度 : 125 mg/mL (336.15 mM; 超声助溶) DMSO 中的溶解度 : 50 mg/mL (134.46 mM; 超声助溶 (<60°C)
-
SMILESCl.N=1C(=CC=CC1C)C=2N=C(NC2C=3C=CC=4OCOC4C3)C(C)(C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. DaCosta Byfield S, et al. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2004 Mar;65(3):744-52.?
产品手册
关联产品
-
INCB-000928
Zilurgisertib (INCB-000928; NBU-928) 是一种选择性的 ALK 2 抑制剂,用于研究癌症等疾病。
-
Blu-782
Blu-782 是一种激活素受体样激酶 2 (ALK2) 抑制剂(IC50 <10 nM)。
-
Zotizalkib
Zotizalkib (TPX-0131) 是一种有效、选择性、CNS 渗透性和口服活性的野生型 ALK 抑制剂 (IC50 为 1.4 nM) 和 ALK 抗性突变,例如 G1202R (IC50 为 0.3 nM)、L1196M (IC50 为 0.3 nM)。Zotizalkib 具有很强的抗肿瘤活性。
021-51111890
购物车()
sales@molnova.cn

